{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:28:24Z","timestamp":1785792504295,"version":"3.56.0"},"reference-count":35,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Bladder cancer is characterized by a high recurrence rate and mortality, posing a significant challenge to clinical management. Recently, cuproptosis, a novel form of regulated cell death, has been identified as a potential target for therapeutic intervention in various diseases. The contribution of cuproptosis-related microRNAs (miRNAs) in bladder cancer pathogenesis, however, remains largely unexplored. Therefore, the current study aims to construct a miRNA signature related to cuproptosis for predicting the prognosis and facilitating personalized therapeutic strategies in bladder cancer patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this study, we retrieved transcriptomic data and clinical information pertaining to bladder cancer from publicly available databases, including the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). We identified a set of 19 cuproptosis-related genes through a comprehensive review of relevant literature. Using multivariate Cox regression and LASSO analysis, we constructed a cuproptosis-related miRNA prognostic signature. The Kaplan-Meier (K-M) and receiver operating characteristic (ROC) curves were used to validate the accuracy of prediction. Additionally, we developed a nomogram incorporating clinical characteristics and the miRNA signature to further assess its prognostic value. We evaluated the tumor microenvironment (TME) of every patient using immune ESTIMATE, CIBERSORT, and ssGSEA algorithms. We also investigated the differences in tumor mutation burden (TMB) and drug sensitivity between two groups. Finally, we validated the prognostic value of this miRNA signature using the OncomiR dataset.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We developed a panel of eight cuproptosis-associated miRNAs to serve as a prognostic signature. The predictive validity of this signature was determined using Kaplan-Meier and ROC curves, and was found to be acceptable in both the TCGA training, test and total dataset. The prognostic value of this signature was confirmed by univariate and multivariate Cox regression analysis, indicating its applicability as a prognostic factor. The immune cell infiltration was significantly associated with an immunosuppressive phenotype of TME in the high-risk group of patients; meanwhile, patients in the high-risk group had a lower TMB resulted in shorter survival. Notably, higher estimate scores and IC50 value for chemotherapy drugs were observed in the high-risk group, indicating poor response to immune therapy and chemotherapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.7717\/peerj.18530","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T10:14:34Z","timestamp":1732875274000},"page":"e18530","source":"Crossref","is-referenced-by-count":6,"title":["Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis"],"prefix":"10.7717","volume":"12","author":[{"given":"Zhilei","family":"Zhang","sequence":"first","affiliation":[{"name":"The Department of Urology, The First Affiliated Hospital of Shandong Second Medical University, Weifang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The First Affiliated Hospital of Shandong Second Medical University, Weifang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Yu","sequence":"additional","affiliation":[{"name":"The Department of Urology, The First Affiliated Hospital of Shandong Second Medical University, Weifang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[{"name":"The Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[{"name":"The Department of Urology, The First Affiliated Hospital of Shandong Second Medical University, Weifang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"1","key":"10.7717\/peerj.18530\/ref-1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"European Urology"},{"key":"10.7717\/peerj.18530\/ref-2","doi-asserted-by":"publisher","first-page":"1027449","DOI":"10.3389\/fimmu.2022.1027449","article-title":"A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer","volume":"13","author":"Bai","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"10.7717\/peerj.18530\/ref-3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11934-018-0860-6","article-title":"Bladder cancer survivorship","volume":"19","author":"Bhanvadia","year":"2018","journal-title":"Current Urology Reports"},{"issue":"5","key":"10.7717\/peerj.18530\/ref-4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/genes13050851","article-title":"A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma","volume":"13","author":"Bian","year":"2022","journal-title":"Genes"},{"issue":"18","key":"10.7717\/peerj.18530\/ref-5","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-20-3177","article-title":"Correction: influencing the tumor microenvironment: a phase II study of copper depletion using Tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases","volume":"26","author":"Chan","year":"2020","journal-title":"Clinical Cancer Research"},{"issue":"26","key":"10.7717\/peerj.18530\/ref-6","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.1021\/jacs.1c04082","article-title":"Copper centers in the Cryo-EM structure of particulate methane monooxygenase reveal the catalytic machinery of methane oxidation","volume":"143","author":"Chang","year":"2021","journal-title":"Journal of the American Chemical Society"},{"issue":"14","key":"10.7717\/peerj.18530\/ref-7","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.2174\/0929867327666200730214757","article-title":"Copper-induced epigenetic changes shape the clinical phenotype in Wilson\u2019s disease","volume":"28","author":"Fanni","year":"2021","journal-title":"Current Medicinal Chemistry"},{"issue":"2","key":"10.7717\/peerj.18530\/ref-8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamaoncol.2020.6371","article-title":"Tumor mutation burden and cancer treatment","volume":"7","author":"Fusco","year":"2021","journal-title":"JAMA Oncology"},{"issue":"3","key":"10.7717\/peerj.18530\/ref-9","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biology"},{"issue":"7679","key":"10.7717\/peerj.18530\/ref-10","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"issue":"18","key":"10.7717\/peerj.18530\/ref-11","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Research"},{"issue":"2","key":"10.7717\/peerj.18530\/ref-12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The challenges of tumor mutational burden as an immunotherapy biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.7717\/peerj.18530\/ref-13","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1039\/D0CS00609B","article-title":"Advances in multiplexed techniques for the detection and quantification of microRNAs","volume":"50","author":"Jet","year":"2021","journal-title":"Chemical Society Reviews"},{"key":"10.7717\/peerj.18530\/ref-14","doi-asserted-by":"publisher","first-page":"930041","DOI":"10.3389\/fphar.2022.930041","article-title":"Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma","volume":"13","author":"Lv","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.7717\/peerj.18530\/ref-15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/BSR20194337","article-title":"Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer","volume":"40","author":"Lv","year":"2020","journal-title":"Bioscience Reports"},{"issue":"5","key":"10.7717\/peerj.18530\/ref-16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.7717\/peerj.18530\/ref-17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU International"},{"key":"10.7717\/peerj.18530\/ref-18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euros.2023.11.003","article-title":"Microbiome profiling in bladder cancer patients using the first-morning urine sample","volume":"59","author":"Nardelli","year":"2023","journal-title":"European Urology Open Science"},{"issue":"5","key":"10.7717\/peerj.18530\/ref-19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nature Reviews Immunology"},{"key":"10.7717\/peerj.18530\/ref-20","doi-asserted-by":"publisher","first-page":"841814","DOI":"10.3389\/fmolb.2022.841814","article-title":"Selective targeting of cancer cells by copper ionophores: an overview","volume":"9","author":"Oliveri","year":"2022","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"11","key":"10.7717\/peerj.18530\/ref-21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrurol.2011.144","article-title":"Urothelial carcinoma of the bladder: definition, treatment and future efforts","volume":"8","author":"Prasad","year":"2011","journal-title":"Nature Reviews Urology"},{"issue":"3","key":"10.7717\/peerj.18530\/ref-22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"issue":"12","key":"10.7717\/peerj.18530\/ref-23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/medicina59122063","article-title":"Is systemic immune-inflammation index a real non-invasive biomarker to predict oncological outcomes in patients eligible for radical cystectomy?","volume":"59","author":"Russo","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.7717\/peerj.18530\/ref-24","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.7717\/peerj.18530\/ref-25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.18530\/ref-26","doi-asserted-by":"publisher","first-page":"745939","DOI":"10.3389\/fimmu.2021.745939","article-title":"Tumor-experienced human NK cells express high levels of PD-L1 and inhibit CD8(+) T cell proliferation","volume":"12","author":"Sierra","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.7717\/peerj.18530\/ref-27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"6586","key":"10.7717\/peerj.18530\/ref-28","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"7","key":"10.7717\/peerj.18530\/ref-29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"10.7717\/peerj.18530\/ref-30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1146\/annurev.nutr.8.1.235","article-title":"Copper deficiency in humans","volume":"20","author":"Williams","year":"1983","journal-title":"Seminars in Hematology"},{"key":"10.7717\/peerj.18530\/ref-31","doi-asserted-by":"publisher","first-page":"938259","DOI":"10.3389\/fgene.2022.938259","article-title":"Cuproptosis-associated lncRNA establishes new prognostic profile and predicts immunotherapy response in clear cell renal cell carcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Frontiers in Genetics"},{"key":"10.7717\/peerj.18530\/ref-32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Letters"},{"key":"10.7717\/peerj.18530\/ref-33","doi-asserted-by":"publisher","first-page":"990326","DOI":"10.3389\/fgene.2022.990326","article-title":"Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer","volume":"13","author":"Zhang","year":"2022a","journal-title":"Frontiers in Genetics"},{"issue":"1","key":"10.7717\/peerj.18530\/ref-34","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1038\/s41598-022-15251-1","article-title":"A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.18530\/ref-35","doi-asserted-by":"publisher","first-page":"997573","DOI":"10.3389\/fgene.2022.997573","article-title":"Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis","volume":"13","author":"Zhang","year":"2022b","journal-title":"Frontiers in Genetics"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/18530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/18530.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/18530.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/18530.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T10:14:38Z","timestamp":1732875278000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/18530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":35,"alternative-id":["10.7717\/peerj.18530"],"URL":"https:\/\/doi.org\/10.7717\/peerj.18530","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"article-number":"e18530"}}